publicaciones seleccionadas

• artículo académico

  • A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle.  BIOMOLECULES.  15(7). 2025
  • Canine Microencapsulated Probiotic Formulations Modulate Immunity and Improve Acute Diarrhea in Dogs.  PROBIOTICS AND ANTIMICROBIAL PROTEINS.  1-27. 2025
  • From Genetic Engineering to Preclinical Safety: A Study on Recombinant Human Interferons.  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.  26(24). 2025
  • Design and functional characterization of Salmo salar TLR5 agonist peptides derived from high mobility group B1 acidic tail.  FISH & SHELLFISH IMMUNOLOGY.  146. 2024
  • Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment.  PHARMACEUTICS.  16(11). 2024
  • Chitosan Microparticles Enhance the Intestinal Release and Immune Response of an Immune Stimulant Peptide in Oncorhynchus mykiss.  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.  24(19). 2023
  • Isolation, characterization, and immunomodulatory activity evaluation of probiotic strains from colostrum and canine milk.  FRONTIERS IN VETERINARY SCIENCE.  10. 2023
  • New strategy for the design, production and pre-purification of chimeric peptide with immunomodulatory activity in Salmo salar.  FISH & SHELLFISH IMMUNOLOGY.  125:120-127. 2022
  • LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells.  CANCER LETTERS.  414:34-43. 2018
  • Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.  PLOS ONE.  9(8):1-11. 2014